Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease

Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease

Hitoshi Amano,1 Reikei Matsuda,1 Tomohiko Shibata,2 Daisuke Takahashi,1 Shinichiro Suzuki3 1Department of Gastroenterology, Fujisawa Shonandai Hospital, Fujisawa, 2Division of Rheumatology, Department of Internal Medicine, St Marianna University School of Medicine, Yokohama City Seibu Hospital, Yoko...

Full description

Bibliographic Details
Main Authors:	Amano H, Matsuda R, Shibata T, Takahashi D, Suzuki S
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-05-01
Series:	Biologics : Targets & Therapy
Subjects:	SAPHO syndrome paradoxical reaction Crohn disease anti-TNF-α therapy adalimumab
Online Access:	https://www.dovepress.com/paradoxical-sapho-syndrome-observed-during-anti-tnf-alpha-therapy-for--peer-reviewed-article-BTT

Similar Items

Uso do pamidronato na síndrome SAPHO Pamidronate treatment in SAPHO syndrome
by: Luana Gerheim Machado, et al.
Published: (2005-12-01)

Sapho syndrome. Tune-up on a clinical case in the CHPR.
by: Juan Miguel Del Castillo Bellón, et al.
Published: (2018-02-01)

Prolonged paradoxical reaction to antituberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation
by: Falkenstern-Ge Roger Fei, et al.
Published: (2015-01-01)

Crohn's Disease: General characteristics and treatment with Adalimumabe biopharmaceutical
by: S. A. Marques, et al.
Published: (2018-02-01)

CROHN'S DISEASE: GENERAL CHARACTERISTICS AND TREATMENT WITH ADALIMUMABE BIOPHARMACEUTICAL
by: S. A. Marques, et al.
Published: (2018-02-01)

SAPHO syndrome the therapeutical challenge
by: Dejanović Bogdan, et al.
Published: (2016-01-01)

The Synovitis, Acne, Pustulosis, Hyperostosis, And Osteitis (SAPHO) syndrome: A two-center study of 23 patients
by: Kaouther Maatallah, et al.
Published: (2022-01-01)

ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
by: Ivaylo Vazharov, et al.
Published: (2016-12-01)

PARADOXICAL CROHN’S DISEASE – MYTH OR REALITY?
by: Cristina Pomirleanu, et al.
Published: (2017-03-01)

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn
by: Víctor Manuel Navas-López, et al.
Published: (2018-02-01)

Comparative efficacy and safety of chimeric and recombinant anti-TNF-α mAbs
by: V. N. Drozdov, et al.
Published: (2021-05-01)

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease
by: Víctor Manuel Navas-López, et al.
Published: (2018-02-01)

The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians
by: Victoria Furer, et al.
Published: (2020-09-01)

Mandibular Involvement in Recurrent Multifocal Osteomyelitis Associated with SAPHO Syndrome
by: Igor-Moreira Hazboun, et al.
Published: (2018-01-01)

Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
by: Neel Sharma, et al.
Published: (2009-11-01)

Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa
by: Farida Benhadou, et al.
Published: (2018-01-01)

Systemic Amyloidosis with Renal Failure: A Challenging Diagnosis of SAPHO Syndrome
by: Cristina Pires Correia, et al.
Published: (2019-03-01)

Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition
by: Rui M. Gomes, et al.
Published: (2013-11-01)

Olga Nethersole and the <i>Sapho</i> scandal
by: Callis, Ann Everal
Published: (1974)

Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis
by: Sho Watanabe, et al.
Published: (2017-01-01)

Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease
by: Mauro Mastronardi, et al.
Published: (2019-11-01)

Analysis and evaluation of the cost of the treatment anti-TNFα in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose
by: Félix Gómez-De Rueda, et al.
Published: (2017-06-01)

Abundance alteration of nondominant species in fecal-associated microbiome of patients with SAPHO syndrome
by: Jianhua Zhen, et al.
Published: (2021-05-01)

Astonishing improvement of destructive mandibular osteomyelitis by NSAIDs: A rare lesion site in a patient with SAPHO syndrome
by: Masaki Tago, et al.
Published: (2019-09-01)

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease – case report
by: Edyta Lelonek, et al.
Published: (2015-09-01)

Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO), and chronic recurrent multifocal osteomyelitis (CRMO): A tale of two cases
by: Balaji Zacharia, et al.
Published: (2021-10-01)

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with a cervical vertebral fracture: A case report
by: Allen Nedley, et al.
Published: (2021-03-01)

Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
by: Simone Garcovich, et al.
Published: (2019-03-01)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
by: Beraldo RF, et al.
Published: (2020-08-01)

Anti-TNF Therapy in Crohn’s Disease
by: Samuel O. Adegbola, et al.
Published: (2018-07-01)

SAPHO syndrome with pathological fractures of vertebral bodies: a case report
by: Yalong Li, et al.
Published: (2019-01-01)

SAPHO syndrome with acne fulminans and severe polyosteitis involving axial skeleton
by: B Lakshmi Divya, et al.
Published: (2016-01-01)

Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
by: Wei-Chen Lin, et al.
Published: (2017-10-01)

SAPHO syndrome: the clinical case
by: T. P. Makarova, et al.
Published: (2017-11-01)

Complicações Imediatas de 3.555 aplicações de agentes anti-TNFα Immediate complications of 3,555 injections of anti-TNFα
by: Júlio César Bertacini de Moraes, et al.
Published: (2010-04-01)

Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
by: Glenn Harvin, et al.
Published: (2016-05-01)

Complicações Imediatas de 3.555 aplicações de agentes anti-TNFα
by: Júlio César Bertacini de Moraes, et al.

Bone histomorphometric and immunohistological analysis for hyperostosis in a patient with SAPHO syndrome: A case report
by: Shun Watanabe, et al.
Published: (2020-12-01)

NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report Las mutaciones de NOD2, CD14 y TLR4 no influyen sobre la respuesta al adalimumab en pacientes con enfermedad de Crohn: informe preliminar
by: M. Barreiro-de Acosta, et al.
Published: (2010-10-01)

Genome-Wide Association Identifies Risk Pathways for SAPHO Syndrome
by: Ruikun Cai, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_rk73e1sakmlgb4seokukco3tdt